About The Authors
Anshul Mangal is co-founder and president of Project Farma and Precision for Medicine’s Manufacturing Solutions, as well as a board member at the Alliance for Regenerative Medicines, Alliance for mRNA Medicines and IQHQ. Prior to his tenure at Project Farma, Mangal was a patent litigator at Jones Day.
As executive vice president of Project Farma, Tony Khoury spearheaded the firm’s growth in the biotech space with a focus on next-generation medicines. He has supported the industrialization of many of the first FDA-approved advanced therapies and led the creation of Project Farma’s Advanced Therapy Manufacturing Playbook.
The cell and gene therapy (CGT) space continues to make headlines and stand out as a beacon of innovation and opportunity, attracting considerable attention from investors and biotech developers. Reports...
CGTs have emerged at the forefront of biotech, offering promising solutions to address a number of previously unmet medical needs across diverse patient populations. With over 2,500 advanced therapy developers...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?
